Phase III randomized trial of pegylated liposomal doxorubicin plus carboplatin versus carboplatin in platinum-sensitive patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy: Southwest Oncology Group Protocol S0200 [Abstract]

Category Primary study
Year 2007
Loading references information
This article has no abstract
Epistemonikos ID: 82b2ed99199ed22c4e4fb514fba0196ac430a9bd
First added on: May 12, 2020